Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

7.93
Delayed Data
As of 3:59pm ET
 -0.36 / -4.34%
Today’s Change
5.57
Today|||52-Week Range
10.95
-26.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues33.8M31.6M0.000.00
 
 
 
Depreciation And Amortization184.0K189.0K192.0K240.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----192.0K-240.0K
 
 
 
General Expenses16.9M15.0M18.6M19.1M
 
 
 
 
 
Research And Development12.2M9.8M13.3M14.2M
 
 
 
 
 
Total Operating Expenses17.1M15.2M18.8M19.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.7M16.4M-18.8M-19.4M
 
 
 
 
 
Interest Expense On Debt12.0K13.0K15.0K12.0K
 
 
 
 
 
Other Expenses8.9M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income26.0M16.8M-18.1M-18.6M
 
 
 
 
 
Income Taxes-245.0K-140.0K-65.0K-60.0K
 
 
 
 
 
Net Income26.3M17.0M-18.1M-18.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS136.4M136.6M136.6M136.7M
 
 
 
 
 
Shares To Calculate EPS Diluted140.0M140.5M136.6M136.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.19$0.12-$0.13-$0.14
 
 
 
 
 
EPS Diluted$0.19$0.12-$0.13-$0.14